Toledo, Diana M.
Pioli, Patricia A.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R56-AR0639835 and R03-AR068097)
Scleroderma Foundation (N/A)
National Institutes of Health p50 Specialized Center Grant, Research Diversity Supplement (3P50AR060780 - 07W1)
John H. Copenhaver, Jr. and William H. Thomas, MD 1952 Junior Fellowship from Dartmouth Graduate Studies (N/A)
Article History
First Online: 23 May 2019
Compliance with Ethical Standards
:
: Ms. Toledo reports grants from NIH and from Dartmouth Graduate Studies, during the conduct of the study.Dr. Pioli reports grants from Celdara Medical, LLC, grants from NIH/NIAMS, and grants from Scleroderma Foundation, during the conduct of the study; in addition, Dr. Pioli has a patent Cellular Based Therapies Targeting Disease-Associated Molecular Mediators of Fibrotic, Inflammatory, and Autoimmune Conditions pending.
: This article does not contain any studies with human or animal subjects performed by any of the authors.